BRAIx Predicts Short-Term Breast Cancer Risk

An Australian study published in The Lancet Digital Health today finds that an AI tool, BRAIx, predicted short-term breast cancer risk among women with clear mammograms. Across 95,823 Australian patients (1.1% developed cancer within four years) and 4,430 Swedish patients (6.9% within two years), BRAIx identified higher risk one to two years after clear screens, with lower accuracy at three to four years. The tool is now being trialled in Victoria.